Exploring Virtual Reality in Clinical Care - Impacts on Patient Distress, Parental Anxiety and Nurse Satisfaction
Retrospective Observational Study Analyzing De-identified Data Originally Collected as Part of a Quality Improvement (QI) Initiative.
1 other identifier
observational
168
1 country
1
Brief Summary
Prior experience with virtual reality (VR) in clinical care has demonstrated its potential to reduce patient anxiety and distress, particularly in pediatric settings. VR has been shown to effectively decrease preoperative anxiety in children undergoing various medical procedures, including IV catheter replacement, blood draws, and improve their compliance with anesthesia and overall procedural experiences. Limited evidence exists regarding the impact of VR on the broader care environment, including parental anxiety and nursing satisfaction in pediatric settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFirst Submitted
Initial submission to the registry
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
December 12, 2025
CompletedDecember 12, 2025
December 1, 2025
9 months
December 1, 2025
December 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in patient anxiety levels, as measured by heart rate
Change in patient anxiety levels, as measured by heart rate, before and after VR intervention. Baseline heart rate will be compared to the heart rate after the intervention.
Before and after VR intervention, one visit only
Change in patient anxiety levels, as measured by blood pressure
Change in patient anxiety levels, as measured by blood pressure, before and after VR intervention. Baseline blood pressure will be compared to the blood pressure after the intervention.
Before and after VR intervention, one visit only
Change in patient anxiety levels, as measured by distress/fear scores
Change in patient anxiety levels, as measured by distress/fear scores before and after VR intervention Baseline distress/fear scores will be compared to the distress/fear scores after the intervention. Using the Children's Fear Scale (CFS) (0-4): * 0 = no fear (good) * 4 = very high fear (bad) . Higher scores indicate worse anxiety. Anxiety levels were measured immediately before and immediately after the VR intervention).
Before and after VR intervention, one visit only
Secondary Outcomes (2)
Parental anxiety levels
Before and after VR intervention, one visit only
Nurse satisfaction ratings
Before and after VR intervention, one visit only
Study Arms (3)
Pediatric Patients
Pediatric patients receiving VR interventions (6-15 years)
Parent Caregivers
Parents of Pediatric patients receiving VR interventions (6-15 years)
Nurses
The nursing staff are involved in the care process of the Pediatric patients receiving VR interventions (6-15 years)
Interventions
Administered as part of a QI initiative aimed at reducing anxiety in pediatric patients during clinical care. The intervention involved using a VR system to provide a distraction and relaxation tool during routine procedures. This approach is consistent with recent research showing that VR can be an effective tool for reducing pain and anxiety in pediatric patients undergoing medical procedures. Retrospective data collection.
Survey responses from parents regarding anxiety and satisfaction.
Survey responses from nurses regarding anxiety and satisfaction.
Eligibility Criteria
The study involved pediatric patients who received VR intervention as part of the original QI initiative. Data protection and de-identification procedures were rigorously applied throughout the study
You may qualify if:
- pediatric patients who received VR intervention as part of the original QI initiative.
- pediatric patients who were eligible and received VR during the QI initiative aged 6-15 years.
You may not qualify if:
- Patients with developmental delays, head injuries, or seizures were excluded from the study.
- Caregivers/Parents
- \- pediatric patients who were eligible and received VR during the QI initiative, aged 6-15 years
- \- N/A
- Nurses
- nurses of pediatric patients who were eligible and received VR during the QI initiative, aged 6-15 years
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dayanjan Wijesinghe
Virginia Commonwealth University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2025
First Posted
December 12, 2025
Study Start
October 1, 2023
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
December 12, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share